A new report has issued a formal recommendation: adults aged 60 and older should get vaccinated against respiratory syncytial virus (RSV). RSV is a common virus that can cause serious lung infections, especially in older people. This recommendation is based on the understanding that RSV poses a significant health risk to this age group and that vaccines are now available.
The report does not provide new data on how effective the vaccines are or how safe they are for this population. It is a guidance document, not a clinical trial. It also does not specify which of the available RSV vaccines to choose or detail the exact timing for vaccination.
This means if you or a loved one is over 60, you now have a clear, official suggestion to consider the RSV shot. However, you should talk with a doctor to decide if it's right for your specific health situation. The recommendation is a starting point for that conversation, not a final answer for every individual.